BBVA USA Bancshares’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,198
Closed -$1.31M 681
2019
Q3
$1.31M Sell
13,198
-73
-0.6% -$6.94K 0.08% 200
2019
Q2
$1.23M Buy
13,271
+111
+0.8% +$10.5K 0.07% 220
2019
Q1
$1.24M Sell
13,160
-501
-4% -$43.8K 0.08% 211
2018
Q4
$876K Sell
13,661
-3,255
-19% -$240K 0.06% 246
2018
Q3
$1.51M Sell
16,916
-215
-1% -$19K 0.09% 208
2018
Q2
$1.36M Buy
17,131
+113
+0.7% +$9.38K 0.09% 210
2018
Q1
$1.52M Sell
17,018
-770
-4% -$73.9K 0.1% 204
2017
Q4
$1.86M Sell
17,788
-4,112
-19% -$464K 0.12% 175
2017
Q3
$3.19M Sell
21,900
-979
-4% -$133K 0.21% 116
2017
Q2
$2.97M Sell
22,879
-1,600
-7% -$196K 0.2% 118
2017
Q1
$3.04M Buy
24,479
+185
+0.8% +$22.1K 0.2% 112
2016
Q4
$2.81M Sell
24,294
-184
-0.8% -$20.5K 0.2% 121
2016
Q3
$2.56M Sell
24,478
-1,104
-4% -$119K 0.19% 121
2016
Q2
$2.52M Sell
25,582
-749
-3% -$77.5K 0.19% 123
2016
Q1
$2.64M Buy
26,331
+2,776
+12% +$286K 0.2% 112
2015
Q4
$2.82M Buy
23,555
+4,557
+24% +$527K 0.21% 113
2015
Q3
$2.06M Sell
18,998
-1,299
-6% -$161K 0.16% 131
2015
Q2
$2.35M Sell
20,297
-1,783
-8% -$204K 0.13% 147
2015
Q1
$2.54M Sell
22,080
-6,624
-23% -$792K 0.11% 176
2014
Q4
$3.21M Sell
28,704
-4,049
-12% -$427K 0.15% 162
2014
Q3
$3.1M Sell
32,753
-20,033
-38% -$1.81M 0.14% 166
2014
Q2
$4.53M Sell
52,786
-13,652
-21% -$1.04M 0.2% 139
2014
Q1
$4.64M Sell
66,438
-486
-0.7% -$38.5K 0.21% 136
2013
Q4
$5.65M Sell
66,924
-720
-1% -$57K 0.25% 130
2013
Q3
$5.21M Sell
67,644
-3,188
-5% -$223K 0.25% 129
2013
Q2
$4.14M Buy
+70,832
New +$4.26M 0.21% 139

Other funds holding CELG

BBVA USA Bancshares's CELG Position: Q4 2019 in Review

BBVA USA Bancshares sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 13,198 shares — an estimated $1.31M sold.

BBVA USA Bancshares first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $5.65M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • BBVA USA Bancshares reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • BBVA USA Bancshares sold 13,198 Celgene Corp shares in Q4 2019, an estimated $1.31M.
  • BBVA USA Bancshares first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • BBVA USA Bancshares's Celgene Corp position peaked at $5.65M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on BBVA USA Bancshares's 13F filing for Q4 2019, filed 3 Feb 2020.